1. Home
  2. AOSL vs PHAR Comparison

AOSL vs PHAR Comparison

Compare AOSL & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha and Omega Semiconductor Limited

AOSL

Alpha and Omega Semiconductor Limited

HOLD

Current Price

$37.25

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$11.94

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AOSL
PHAR
Founded
2000
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
AOSL
PHAR
Price
$37.25
$11.94
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$24.00
$38.33
AVG Volume (30 Days)
1.1M
8.7K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$342,291,000.00
N/A
Revenue This Year
N/A
$10.04
Revenue Next Year
$6.41
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$17.01
$8.69
52 Week High
$49.97
$21.34

Technical Indicators

Market Signals
Indicator
AOSL
PHAR
Relative Strength Index (RSI) 51.46 20.60
Support Level $26.82 $11.02
Resistance Level $45.97 $17.70
Average True Range (ATR) 4.47 0.37
MACD -0.26 -0.37
Stochastic Oscillator 15.84 3.49

Price Performance

Historical Comparison
AOSL
PHAR

About AOSL Alpha and Omega Semiconductor Limited

Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries. It operates in one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: